Correlation of vascular endothelial growth factor expression with tumor recurrence and poor prognosis in patients with pN0 gastric cancer

World Journal of Surgery

Volumn 36, Issue 1, 2012, Pages 109-117

  Liu, Yan Feng ^a   Guo, Sen ^a   Zhao, Rui ^a   Chen, Yue Guang ^a   Wang, Xian Qiang ^a   Xu, Ke Sen ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; TUMOR MARKER; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; EVALUATION; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; STOMACH TUMOR; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84866021272     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-011-1192-6     Document Type: Article

References (37)

1. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12:354-362
2. Leung DW, Cachianes G, Kuang WJ et al (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309
3. Maeda K, Kang SM, Onoda N et al (1998) Expression of p53 and vascular endothelial growth factor associated with tumor angiogenesis and prognosis in gastric cancer. Oncology 55:594-599
4. Song ZJ, Gong P, Wu YE (2002) Relationship between the expression of iNOS, VEGF, tumor angiogenesis and gastric cancer. World J Gastroenterol 8:591-595
5. Maeda K, Chung YS, Ogawa Y et al (1996) Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77:858-863
6. Vidal O, Soriano-Izquierdo A, Pera M et al (2008) Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers. J Gastrointest Surg 12:1005-1014
7. Yasuda K, Adachi Y, Shiraishi N et al (2002) Prognostic effect of lymph node micrometastasis in patients with histologically nodenegative gastric cancer. Ann Surg Oncol 9:771-774
8. Parikh RR, Yang Q, Haffty BG (2007) Prognostic significance of vascular endothelial growth factor protein levels in T1-2 N0 laryngeal cancer treated with primary radiation therapy. Cancer 109:566-573
9. Ogura S, Ohdaira T, Hozumi Y et al (2007) Metastasis-related factors expressed in pT1 pN0 breast cancer: assessment of recurrence risk. J Surg Oncol 96:46-53
10. Chien CY, Su CY, Hwang CF et al (2006) High expressions of CD105 and VEGF in early oral cancer predict potential cervical metastasis. J Surg Oncol 94:413-417
11. Green MM, Hiley CT, Shanks JH et al (2007) Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome. Int J Radiat Oncol Biol Phys 67:84-90
12. Herszenyi L, Sipos F, Galamb O et al (2008) Matrix metalloproteinase- 9 expression in the normal mucosa-Adenoma- dysplasia-Adenocarcinoma sequence of the colon. Pathol Oncol Res 14:31-37
13. Zheng H, Takahashi H, Murai Y et al (2006) Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 26:3579-3583
14. Gao ZL, Zhang C, Du GY et al (2007) Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma. Hepatogastroenterology 54:1591-1595
15. Tamura M, Oda M, Matsumoto I et al (2004) The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer. Ann Surg Oncol 11:928-933
16. Hao L, Zhang C, Qiu Y et al (2007) Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer. Cancer Lett 253:34-42
17. Weidner N (1995) Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36:169-180
18. Zhang S, Li L, Lin JY et al (2003) Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase- 1 in invasiveness and metastasis of human gastric carcinoma. World J Gastroenterol 9:899-904
19. Kim DY, Seo KW, Joo JK et al (2006) Prognostic factors in patients with node-negative gastric carcinoma: a comparison with node-positive gastric carcinoma. World J Gastroenterol 12: 1182-1186
20. Kwon SJ, Kim GS (1996) Prognostic significance of lymph node metastasis in advanced carcinoma of the stomach. Br J Surg 83:1600-1603
21. Ohgaki M, Toshio T, Akeo H et al (1999) Effect of extensive lymph node dissection on the survival of early gastric cancer. Hepatogastroenterology 46:2096-2099
22. Kaneko T, Konno H, Baba M et al (2003) Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer. Cancer Sci 94:43-49
23. Yu HG, Li JY, Yang YN et al (2003) Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer. Cancer Lett 195:43-51
24. Ma J, Zhang L, Ru GQ et al (2007) Upregulation of hypoxia inducible factor 1alpha mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma. World J Gastroenterol 13:1680-1686
25. Maeda K, Chung YS, Takatsuka S et al (1995) Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 13:477-481
26. Alexandrakis MG, Sfiridaki A, Miyakis S et al (2007) Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma. Clin Chim Acta 379:31-35
27. Guo RP, Zhong C, Shi M et al (2006) Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma. J Cancer Res Clin Oncol 132:547-555
28. Liu CJ, Chang KW, Lin SC et al (2009) Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma. Oral Oncol 45:920-925
29. Janowska-Wieczorek A, Majka M, Marquez-Curtis L et al (2002) Bcr-Abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants. Leukemia 16:1160-1166
30. Dias S, Hattori K, Zhu Z et al (2000) Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest 106:511-521
31. Owen JL, Iragavarapu-Charyulu V, Gunja-Smith Z et al (2003) Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor. J Immunol 171:4340-4351
32. Zhao R, Liu XQ, Wu XP et al (2010) Vascular endothelial growth factor (VEGF) enhances gastric carcinoma invasiveness via integrin alpha(v)beta6. Cancer Lett 287:150-156
33. Bergers G, Brekken R, McMahon G et al (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737-744
34. Belotti D, Paganoni P, Manenti L et al (2003) Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 63:5224-5229
35. Hawinkels LJ, Zuidwijk K, Verspaget HW et al (2008) VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. Eur J Cancer 44:1904-1913
36. Mori M, Sugimachi K (1990) Clinicopathologic studies of gastric carcinoma. Semin Surg Oncol 6:19-27
37. Kooby DA, Suriawinata A, Klimstra DS et al (2003) Biologic predictors of survival in node-negative gastric cancer. Ann Surg 237:828-835; discussion 835-837